After post hoc analyses, those who benefited most from AngII administration were those with the most severe presentations with a relative AngII deficiency [147] and markedly elevated serum renin concentrations at baseline (ref. AJRCCM 2020). This evidence concerns the gene AGT and hyperinsulinemic hypoglycemia, familial, 4.